Pharmacie Thauvin SRL

Pharmacie Thauvin reported total assets of 156,263 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Aug 2026).

Company number (CBE) 0693.816.452 · VAT BE0693816452
5590 Ciney
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 30 Mar 2018 (≈ 8 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Pharmacie Thauvin shows with a free account.

See the score
Profile
SRL since 2018
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result8,968 €
Equity76,506 €
EBITDA52,741 €
Total assets156,263 €
The line marks its sector median: 41.5% (1048 companies).

Change 2022 → 2025: Equity +57 % Total assets -44 %

Accounts of the company itself (not consolidated).

The full file covers 8 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Pharmacie Thauvin's annual accounts

20252024202320222021
Net result8,968 €
Equity76,506 €
EBITDA52,741 €
Total assets156,263 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 28 Aug 2026
  • Year ended 31 Dec 2024filed on 26 Aug 2025
  • Year ended 31 Dec 2023filed on 29 Aug 2024
  • Year ended 31 Dec 2022filed on 29 Aug 2023
  • Year ended 31 Dec 2021filed on 31 Aug 2022

Pharmacie Thauvin's financial analysis

Management and control of Pharmacie Thauvin

3 active director(s) in the register.

Pharmacie Thauvin's shareholders and holdings →

Pharmacie Thauvin's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0693.816.452
VAT number
BE0693816452
Peppol
Registered · 0208:0693816452 · as of 10 Nov 2026
Legal form
SRL
Incorporated
30 Mar 2018
Registered office
5590 Ciney
Latest accounts
2025 · filed on 28 Aug 2026
Activity
Retail sale of pharmaceutical products (NACE 47730)

Pharmacie Thauvin (SRL) has been based in Ciney since 2018, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 8,968 € and equity of 76,506 €; its revenue is not published. Its solvency stands at 49.0%, above the median of its sector (41.5%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Pharmacie Thauvin

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Pharmacie Thauvin

What is the revenue of Pharmacie Thauvin?

Pharmacie Thauvin files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Pharmacie Thauvin?

In Belgium, the VAT number is the company number prefixed with BE: BE0693816452 for Pharmacie Thauvin, if the company is VAT-registered. Its company number (CBE) is 0693.816.452.

Where is the registered office of Pharmacie Thauvin?

According to the CBE register, the registered office of Pharmacie Thauvin is in 5590 Ciney.

What is the equity of Pharmacie Thauvin?

At the close of the 2025 financial year, the equity of Pharmacie Thauvin amounts to 76,506 €, a solvency of 49.0% of total assets.

Who manages Pharmacie Thauvin?

The register lists 3 active mandates at Pharmacie Thauvin. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Pharmacie Thauvin

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 25 Sep 2026

No credit card, no commitment.

What each plan unlocks →